v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Premiums $ 87,561 $ 86,534
Investment and other income 1,131 1,033
Total revenues 111,721 109,575
Operating costs:    
Medical Costs 73,489 73,411
Operating costs 15,390 13,594
Cost of products sold 12,823 12,390
Depreciation and amortization 1,029 1,061
Total operating costs 102,731 100,456
Earnings from operations 8,990 9,119
Interest expense (955) (998)
Loss on sale of subsidiary and subsidiaries held for sale (72) (15)
Earnings before income taxes 7,963 8,106
Provision for income taxes (1,482) (1,632)
Net earnings 6,481 6,474
Earnings attributable to noncontrolling interests (201) (182)
Net earnings attributable to UnitedHealth Group common shareholders $ 6,280 $ 6,292
Earnings per share attributable to UnitedHealth Group common shareholders:    
Basic $ 6.92 $ 6.90
Diluted $ 6.90 $ 6.85
Basic weighted-average number of common shares outstanding 908 912
Dilutive effect of common share equivalents 2 6
Diluted weighted-average number of common shares outstanding 910 918
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 18 6
Products    
Revenues:    
Revenue from Products and Services $ 13,250 $ 13,036
Services    
Revenues:    
Revenue from Products and Services $ 9,779 $ 8,972